Panadol Cold & Flu Nasal

Quick links

Choose a section

Quick links to important sections

Advertisements

Panadol Cold & Flu Nasal

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Panadol Cold & Flu Nasal

Property Description
Active Ingredients Acetaminophen, Chlorphenamine Maleate, Phenylephrine Hydrochloride
Form Tablet (Oral) or Metered-dose Solution (Nasal Spray)
Pharmacological Class Analgesic, Antipyretic, Antihistamine, Nasal Decongestant
Common Use Symptomatic relief of cold and flu discomforts
Origin Synthetic Fixed-Dose Combination (FDC)

What Type of Medicine is Panadol Cold & Flu Nasal?

Panadol Cold & Flu Nasal is a synthetic fixed-dose combination (FDC) product, typically classified as an Over-the-counter (OTC) medicine used for multi-symptom relief from common cold and flu. This preparation is specifically formulated to address various discomforts concurrently through its synergistic combination of active agents. It is categorized pharmacologically as an agent combining activity from the Analgesic, Antipyretic, H1-receptor Antagonist, and Sympathomimetic Amine (Decongestant) classes, forming a single therapeutic entity. This FDC approach is intended for the symptomatic management of flu-like illnesses in adults. This specific combination is designed to reduce overall cold and flu symptoms, supporting its use when relief from multiple issues is required simultaneously.

Composition: Active Ingredients and Therapeutic Purpose

The formulation contains three primary active ingredients: Acetaminophen, Chlorphenamine Maleate, and Phenylephrine Hydrochloride. Each substance contributes a distinct therapeutic action. Acetaminophen (Paracetamol) functions as a non-opioid analgesic and antipyretic, targeting the relief of generalized aches and fever reduction. Chlorphenamine Maleate is included as a first-generation antihistamine that acts to mitigate allergic-like cold symptoms, specifically reducing issues such as a runny nose. The third component, Phenylephrine Hydrochloride, is a sympathomimetic amine that provides a decongestant effect by causing vasoconstriction in the nasal passages. These ingredients work together to provide multi-component relief from pain, fever, and congestion.

The General Benefit of a Multi-Ingredient Remedy

The essential purpose of this combination product is to provide concurrent and integrated symptomatic relief for the major manifestations of cold and flu, such as when one experiences a blocked nose alongside a fever and head pain. By consolidating therapeutic agents for pain, fever, and nasal obstruction into a single entity, the formulation provides comprehensive counteraction against multiple prevalent symptoms simultaneously. This integrated approach simplifies the process of achieving symptomatic relief by addressing systemic discomfort and localized nasal issues with one course of medicine, a feature distinctive from single-ingredient pain relievers.

Advertisements

What side effects are possible with Panadol Cold & Flu Nasal?

Official Side Effects and Safety Characteristics

The safety profile for this fixed-dose combination (Acetaminophen, Chlorphenamine Maleate, Phenylephrine Hydrochloride) is structured by regulatory bodies (such as the FDA and EMA) based on the known risks of its three active components. Adverse reactions are classified by frequency and System-Organ-Class (SOC) to provide a regulatory definition of potential effects.

Commonly Documented Adverse Reactions

Side effects classified as common often involve the Nervous System and Gastrointestinal System. These frequently reported effects include drowsiness and sedation (due to the antihistamine component), headache, insomnia, nervousness, and dry mouth.

Serious Adverse Reactions and Constraints

The most serious risk documented in official labeling is Severe Hepatotoxicity and potential Acute Liver Failure associated with the Acetaminophen component. This risk is explicitly tied to use that exceeds the maximum recommended daily dose or prolonged, excessive use. Other documented serious effects include rare Severe Cutaneous Adverse Reactions (SCARs) and certain blood dyscrasias.

Cardiovascular effects, such as palpitations or an increase in blood pressure, are officially listed under Cardiac Disorders, linked primarily to the Phenylephrine component.

Population-Specific Safety Notes

Official labels advise that Older Adults may have increased sensitivity to central nervous system effects (e.g., drowsiness) and anticholinergic effects (e.g., urinary retention). Caution is also noted for use in individuals with pre-existing conditions like severe uncontrolled hypertension or hepatic impairment, as defined by regulatory restrictions.

These safety classifications define the medicine's risk profile, focusing on organ toxicity and specific systemic effects, without crossing into therapeutic or dosing instructions.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information

This section outlines the documented overdose manifestations and mandated emergency actions for this multi-component preparation, based strictly on government regulatory documents.

Overdose Scope

Property Official Regulatory Statement
Documented Overdose Presentations Early signs include pallor, nausea, vomiting, and abdominal pain. Delayed signs may include evidence of severe liver damage. Acute symptoms involve CNS effects (sedation, convulsions, excitement) and cardiovascular issues (hypertension, arrhythmias) [SmPC/DailyMed].
Physiological Systems Affected Hepatic system (severe liver damage), Renal system (acute renal failure), Cardiovascular system (hypertensive crisis), and Central Nervous System (coma, seizures) [SmPC].
Emergency-Response Statements Immediate medical advice must be sought in the event of an overdose, even if the patient feels well [SmPC]. Get medical help or contact a Poison Control Center right away [DailyMed]. Prompt medical attention is critical for adults as well as for children [DailyMed].
Antidote and Support The antidote N-acetylcysteine (NAC) is available for the acetaminophen component. Supportive measures include consideration of activated charcoal administration and plasma paracetamol concentration measurement for risk assessment [SmPC].

Regulatory Summary

Regulatory documentation defines a significant risk profile, primarily focused on the delayed potential for severe, sometimes fatal liver damage from the acetaminophen component. This is why immediate medical intervention is essential, without waiting for initial symptoms to develop. The presence of chlorphenamine and the sympathomimetic amine adds acute risks, including potentially life-threatening hypertensive crises and severe CNS excitation, which also mandate urgent hospital attention.

Advertisements

Therapeutic Uses of Panadol Cold & Flu Nasal

This multi-component remedy is commonly used to provide integrated symptomatic relief in adults experiencing the discomforts of the common cold and flu-like illnesses. The product is applied across domains where additional symptomatic support is needed, consistent with therapeutic categories used to temporarily relieve multiple symptoms of cold and allergy. It is relevant in contexts marked by increased discomfort or tension, and it is utilized where additional symptomatic support is needed in situations involving certain distressing symptoms.

This medication is commonly used across conditions presenting with acute episodes and helps address symptom clusters that may appear suddenly, including generalized body aches, head pain, fever, blocked nose (nasal obstruction), and runny nose (rhinorrhea). It generally helps reduce the intensity of systemic discomfort and is commonly used to help with elevated body temperature, which supports patients during difficult episodes by easing distress. It provides supportive relief when symptoms interfere with routine activities, assisting with maintaining functional stability during periods of heightened symptoms.


Quick Fact: Relief for Integrated Symptom Clusters The formulation may assist with managing symptom clusters that appear together, such as pain, fever, and congestion, which is relevant in contexts involving heightened systemic burden.

Regulatory References

  1. Label: RESFRIOL D- acetaminophen, chlorpheniramine maleate, phenylephrine hcl tablet – DailyMed
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Panadol Cold & Flu Nasal?

The population eligibility for this fixed-dose combination product (Acetaminophen, Chlorphenamine Maleate, and Phenylephrine Hydrochloride) is strictly defined by regulatory documents, establishing who is permitted to use the medicine and who is prohibited.


Eligibility and Exclusion Criteria

Classification Rule Summary (Based on Official Labeling)
Allowed Population Generally Adults and Children 12 years of age and over.
Absolute Prohibition (Contraindicated) Patients with known Hypersensitivity to any component, or those currently taking or recently having taken a Monoamine Oxidase Inhibitor (MAOI).
Comorbidity Exclusion Contraindicated in patients with Severe Hypertension, Severe Cardiovascular Disease, Phaeochromocytoma, Closed-angle Glaucoma, or Severe Hepatic/Renal Impairment.

Age and Special Populations

Age-Related Use: The product is not recommended for children under 12 years of age. Older adults are advised to use with caution.

Pregnancy and Lactation: Use is not recommended and is restricted. A health professional must be consulted before use during pregnancy or while breastfeeding.

Conditional Use: Patients with non-severe Heart Disease, Diabetes Mellitus, Hyperthyroidism, or non-severe Liver/Kidney Disease require caution and medical consultation before use.

Advertisements

What should I know about interactions with other medicines?

This product contains two active ingredients, paracetamol (for pain/fever) and a sympathomimetic amine (a nasal decongestant, e.g., phenylephrine or pseudoephedrine), each with its own interaction profile.

Contraindicated and Restricted Combinations

Category/Mechanism Interacting Products Key Restriction
Sympathomimetic Effect Monoamine Oxidase Inhibitors (MAOIs), Tricyclic Antidepressants, other Sympathomimetic Amines (e.g., decongestants, amphetamine-like stimulants) Do not use with MAOIs or within 2 weeks of stopping an MAOI due to risk of hypertensive crisis. Additive effects with other sympathomimetics increase cardiovascular risk.
Paracetamol Overdose Any other product containing paracetamol (acetaminophen) Do not use concurrently to avoid exceeding the maximum daily dose, which can lead to severe liver damage.

Use with Caution and Monitoring

  • Antihypertensives (e.g., beta-blockers, methyldopa): The decongestant component may reduce the efficacy of these medicines and increase the risk of hypertension and other cardiovascular side effects.
  • Oral Anticoagulants (e.g., warfarin): Prolonged regular daily use of paracetamol may enhance the anticoagulant effect, increasing the risk of bleeding. Occasional doses are not considered significant.
  • Hepatotoxic Drugs / Enzyme Inducers: The risk of paracetamol toxicity is increased when taken with other potentially hepatotoxic drugs or agents that induce liver microsomal enzymes (e.g., certain anticonvulsants).
  • Absorption Rate Modifiers: The speed of paracetamol absorption is increased by medicines that increase gastric emptying (e.g., metoclopramide) and decreased by agents that delay it (e.g., propantheline). Cholestyramine reduces paracetamol absorption if administered within one hour.
Advertisements

Mechanism of Action

Central Regulation of Pain and Temperature

This mechanistic domain centers on Acetaminophen's targeted inhibition of Cyclooxygenase ( COX) isoforms primarily within the Central Nervous System (CNS). This action reduces the synthesis of Prostaglandin E2 ( PGE2) in the hypothalamus, which initiates the resetting of the thermoregulatory set point and contributes to the modulation of nociceptive signal transmission.


Targeted Vasoconstriction in Nasal Mucosa

The decongestant mechanism relies on Phenylephrine's selective activation (agonism) of the Alpha-1 Adrenergic Receptors (alpha1) located on the smooth muscle of the nasal blood vessels. This alpha1 agonism initiates a sustained vascular smooth muscle contraction (vasoconstriction), which physically reduces the volume and thickness of the nasal mucosa.


Blockade of Histamine and Secretion Pathways

Chlorphenamine Maleate acts within this domain as an inverse agonist on the Histamine H1 Receptor, functionally blocking the effects of the inflammatory mediator histamine on blood vessels and nerve endings. This diminishes vascular permeability and glandular output, inhibiting the underlying histamine-driven increase in vascular permeability and glandular output.

Advertisements

Dosage and Administration Information

The administration of this product involves its oral fixed-dose combination (FDC) components and, separately, its potential nasal administration form. The most common route for the Acetaminophen, Chlorphenamine Maleate, and Phenylephrine FDC is Oral (tablet, caplet, or powder for solution). Products containing only the decongestant component (Phenylephrine) may be administered via the Nasal route as a spray or metered-dose solution, which utilizes a distinct administration pattern.

Administration Pattern and Dosage

For the oral tablet FDC, the standard dose for adults and adolescents 12 years and older is typically 1 to 2 tablets, based on the specific formulation's strength. Administration is on an intermittent schedule, conditioned by need, and adheres to a minimum time interval. Dosing is not to be repeated more frequently than every 4 to 6 hours.

Limits and Special Conditions

The maximum daily limit for total intake is 6 tablets in a 24-hour period for a standard 500 mg Acetaminophen combination. The oral unit is taken by swallowing whole with water; the tablet is not to be crushed, chewed, or dissolved. If administered as a powder, the dose must be fully dissolved in hot water prior to intake.

Duration of Use

This medication is intended for short-term use only. The continuous administration of the oral FDC is restricted to a maximum of 7 consecutive days. The nasal decongestant component, when used as a single agent, has a stricter duration limit, typically not exceeding 3 consecutive days.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Panadol Cold & Flu Nasal

Evidence for Symptomatic Relief of Cold and Flu Clusters

Research examined the combination of ingredients in this product in contexts associated with acute conditions characterized by fluctuating or episodic manifestations of the common cold. The research base primarily consists of short-term, randomized, double-blind, placebo-controlled trials (RCTs). These studies were applied in research contexts involving fluctuating or unstable symptoms, specifically focusing on how symptoms change over defined time intervals.

Researchers mainly examined outcomes related to systemic or functional imbalance, such as the patient-reported perceived discomfort across a cluster of symptoms (like nasal congestion, fever, and pain). Studies monitored changes in overall symptom severity scores over short observation periods, typically 48 to 72 hours. The research also explored outcomes reflecting daily functioning or activity level, measuring outcomes related to the time participants reported to resume their usual daily activity. Findings describe patterns observed in these short-term studies, and research highlights changes measured during the study period.


Observation Periods and Duration of Study Follow-Up

The core evidence is relevant in trials assessing short-term or episodic symptom patterns and often focuses on measurements observed within the first few days. The typical follow-up durations were limited, with most pivotal trials observing responses over defined time intervals of 48 hours to 72 hours. While studies report how symptoms evolved in the observed populations during these acute episodes, there is limited information for long-term outcomes. Therefore, long-term effects are not fully established, and evidence derived from settings with varying symptom burdens provides insight only into these short-term changes. Research is ongoing to better characterize effects over extended periods.


Evidence in Specific Patient Populations

The majority of data show patterns related to use in adults between the ages of 18 and 60, who were observed in studies during periods of increased symptom activity from the common cold. Systematic reviews, which look across many individual trials, have also incorporated data related to older children. However, data for certain groups remain insufficient. Specifically, research provides limited context regarding the effect of the combination in young children (infants and toddlers), as clinical trials for this age group have been restricted. The results apply only to the populations studied in the research and do not determine whether an individual in a different group will respond similarly.


Clinical Study Landscape and Evidence Quality

The research base for this product includes RCTs, systematic reviews, and meta-analyses, contributing to a Moderate level of evidence. The certainty of the evidence varies across studies, and some findings were observed in trials involving modest sample sizes. Research describes patterns related to short-term change and helps contextualize how patients reported their experience when symptoms became more noticeable. However, comparative evidence is lacking for certain aspects. Specifically, there is limited data exploring the value of the fixed-dose combination compared to taking its three active ingredients separately.


Areas of Research Uncertainty and Study Gaps

A key limitation of the existing research is the limited data available that directly compares this specific three-ingredient fixed-dose combination to its single components. This means that the added value of combining all three ingredients into one product is not fully established by comparison trials. Furthermore, subgroup findings are uncertain, as data show patterns related to smaller changes in individual symptom scores compared to the changes measured for the overall symptom cluster. The evidence highlights what is known—and what is still uncertain—about this combination.

Key Studies & References

  1. Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome (NCT01389518)
  2. Label: MULTI-SYMPTOM ALLERGY- acetaminophen, chlorpheniramine maleate, phenylephrine hcl tablet, coated (DailyMed Monograph)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Panadol Cold & Flu Nasal (FAQ)


Q: Does this product only target nasal congestion, or does it also help with pain and fever?

Regulatory documents state that this medicine is a fixed-dose combination, meaning it contains multiple active ingredients. These ingredients work together to address both localized symptoms like nasal congestion and systemic symptoms like pain and fever.

Q: Is it possible to experience a 'rebound congestion' effect with this product?

Official duration guidelines restrict the continuous use of the nasal decongestant component to a maximum of three consecutive days. The restriction reflects regulatory caution associated with the extended use of nasal decongestants.

Q: Can a person take Panadol Cold & Flu Nasal if they are already taking other Paracetamol-containing medicines?

Official regulatory documents explicitly advise against using this product concurrently with any other product containing paracetamol (acetaminophen). This warning is in place to help prevent exceeding the maximum recommended daily dose, which is tied to the risk of liver damage.

Q: What is the recommended period of use before a person should seek medical advice?

Official documents describe criteria for when to stop using the product and consult a health professional. This typically includes if symptoms of pain or congestion worsen or persist beyond seven days, or if a fever worsens or lasts more than three days.

Q: Why do official sources sometimes advise avoiding this drug if one has an enlarged prostate?

Warnings are issued because the decongestant component of the medicine can potentially affect conditions like an enlarged prostate gland. This warning is related to the decongestant component’s potential systemic effects.

Q: Does this medicine contain an antihistamine?

Yes, official product information confirms the medicine contains Chlorphenamine Maleate, which is categorized as an antihistamine. This ingredient is included for its potential to help relieve allergy-like cold symptoms such as a runny nose.

Q: Is it safe to drink alcohol while taking Panadol Cold & Flu Nasal?

Official warnings describe an increased risk associated with consuming alcohol while using this medication. This guidance is due to the potential for increased risk of liver damage.

Q: Can this product cause unusual bruising or bleeding?

Official adverse reaction reports include blood dyscrasias, which are rare but serious conditions. Furthermore, prolonged regular daily use of the paracetamol component may enhance the effect of oral anticoagulants (blood thinners), potentially increasing the risk of bleeding.

Q: How quickly can a user generally expect to feel relief after using Panadol Cold & Flu Nasal?

Pharmacokinetic data describes the timing of absorption for the active components. Official information indicates that peak concentrations in the bloodstream occur between approximately 10 to 60 minutes after oral administration.

Q: How long do the effects of one dose of the medicine typically last?

Official directions for use specify a minimum interval between doses. The dosing schedule generally restricts the administration of the oral tablet to no more frequently than every four to six hours.

Q: Does using this product help shorten the duration of a cold or flu, or only manage symptoms?

Official documents describe the medicine's use as being for the temporary symptomatic relief of common cold and flu discomforts. The medicine is described as focusing on the temporary management of symptoms.

Q: What kind of interactions should I be aware of with common medicines like blood thinners?

Regulatory documents advise that prolonged regular daily use of the paracetamol component may enhance the effect of oral anticoagulants, such as warfarin. This interaction is noted as potentially increasing the risk of bleeding.

Q: Is it safe to use this product at the same time as cold remedies like Lemsip or Benylin?

Regulatory documents explicitly advise against using this product concurrently with any other product containing paracetamol (acetaminophen). The reason is to avoid exceeding the maximum daily dose limit and the potential for associated liver risks.

Q: What are the most common side effects described for this product?

Commonly documented adverse reactions often involve the Nervous System and Gastrointestinal System. These effects may include drowsiness, sedation, headache, nervousness, insomnia, and dry mouth.

Q: Is there official research evidence confirming the claims for this specific formulation?

Research, including short-term, randomized, double-blind, placebo-controlled trials, has examined the combination of ingredients. These studies provide context for the product’s use in managing acute common cold symptoms.

Q: Does the product help with a sore throat, or is it only for nasal symptoms?

Official indications list the temporary relief of sore throat, headache, and minor aches and pains, in addition to nasal congestion. This is due to the fever-reducing and pain-relieving component.

Q: What should a user do if they accidentally miss a dose?

Official instructions specify that if a dose is missed, administration should follow the prescribed timing logic, avoiding taking a dose too close to the next scheduled administration. It is explicitly advised never to take a double dose to compensate.

Q: Is it described as being suitable for people with diabetes?

Official documents classify diabetes as a conditional use, rather than an outright prohibition. Regulatory documents indicate that consultation with a health professional is advised prior to use in this population.

Q: What is the meaning of the specific safety warnings related to MAOIs (Monoamine Oxidase Inhibitors)?

The warnings are in place because the decongestant component can interact with MAOIs, potentially leading to a severe and dangerous increase in blood pressure. This severe reaction is often described in literature as a hypertensive crisis.

Q: Why do some people experience dizziness after taking this medicine?

The medicine's active components, particularly the antihistamine, are documented to cause effects on the central nervous system. Official information indicates that if dizziness occurs, this is a criterion for stopping use and seeking consultation with a health professional.

Q: Does Panadol Cold & Flu Nasal help with body aches and pains?

Official indications list the temporary relief of minor aches and pains, along with headache and fever. This is a core function provided by the Acetaminophen component of the combination product.

Q: What should a user do if the product seems to make their congestion worse?

Regulatory warnings indicate that worsening nasal congestion is a criterion for stopping use and seeking consultation with a health professional. This is a stop-use criterion listed in the official instructions.

Q: Is there any difference in effect between taking the tablet with food or on an empty stomach?

Pharmacokinetic data for the medicine shows that food intake may cause a delay in the absorption rate of the Paracetamol component. This change relates to the rate at which the drug is absorbed into the body.

Advertisements

How should Panadol Cold & Flu Nasal be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory documentation sets mandatory conditions for the storage and disposal of this medicine to ensure product stability and safety.

Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature, generally below 25°C (77°F), and avoid excessive heat above 40°C.
Protection Keep in the original container, protected from light and moisture.
Stability Do not use the medicine after the expiry date printed on the packaging.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused medicine should be disposed of via an official drug take-back program or an authorized collector.

If no take-back program is available, the product can be discarded in household trash by mixing it with an undesirable substance, such as dirt or used coffee grounds, placing the mixture in a sealed container. The medicine must not be flushed down the toilet or poured down the drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panadol Cold & Flu Nasal found in:

A-Z Index: